RB137 recognizes LL37 in neutrophil-extracellular trap-like (NET) structures in systemic lupus erythematosus and rheumatoid arthritis inflamed tissues by immunofluorescence in histological sections
Besides being a natural antibiotic, the human cathelicidin LL37, produced by epithelial cells and neutrophils, is an important immune-modulator. LL37 alone, or in complex with DNA, can activate inflammatory pathways in psoriasis, Systemic Lupus Erythematosus (SLE) and Rheumatoid Arthritis (RA). In this work, we describe the capacity of the recombinant monoclonal antibody RB137, previously shown to specifically recognize LL37 in its native form by ELISA, to detect LL37 by immunofluorescence in human tissues derived from SLE and RA patients. In these tissues, LL37 decorates DNA filaments resembling neutrophil-extracellular-trap (NET) structures. This antibody represents a valuable tool to detect the presence, the native state and the exact localization of LL37 in human tissues in health and disease.
Boeltz S, Amini P, Anders HJ, et al. To NET or not to NET: current opinions and state of the science regarding the formation of neutrophil extracellular traps. Cell Death Differ. 2019; 26:395-408. PMID: 30622307
Cecchi I, Arias de la Rosa I, Menegatti E, et al. Neutrophils: Novel key players in Rheumatoid Arthritis. Autoimmun Rev. 2018; 17:1138-1149. PMID: 30217550.
Frangou E, Vassilopoulos D, Boletis J, Boumpas DT. An emerging role of neutrophils and NETosis in chronic inflammation and fibrosis in systemic lupus erythematosus (SLE) and ANCA-associated vasculitides (AAV): Implications for the pathogenesis and treatment. Autoimmun Rev. 2019; 18:751-760. PMID: 31181324.
Hancock RE, Haney EF, Gill EE. The immunology of host defence peptides: beyond antimicrobial activity. Nat Rev Immunol. 2016; 16:321-34. PMID: 27087664.
Kilsgård O, Andersson P, Malmsten M, et al. Peptidylarginine deiminases present in the airways during tobacco smoking and inflammation can citrullinate the host defense peptide LL-37, resulting in altered activities. Am J Respir Cell Mol Biol. 2012; 46:240-8. PMID: 21960546.
Kissel T, Reijm S, Slot LM, et al. Antibodies and B cells recognising citrullinated proteins display a broad cross-reactivity towards other post-translational modifications. Ann Rheum Dis. 2020; 79:472-480. PMID: 32041746.
Koro C, Hellvard A, Delaleu N, et al. Carbamylated LL-37 as a modulator of the immune response. Innate Immun. 2016; 22:218-29. PMID: 26878866
Lande R, Palazzo R, Hammel P, et al. Generation of monoclonal antibodies specific for native LL37 and citrullinated LL37 that discriminate the two LL37 forms in the skin and circulation of cutaneous/systemic lupus erythematosus and rheumatoid arthritis patients. Antibodies (Basel) 2020a; 9:e14. PMID: 32403306.
Lande R, Palazzo R, Pietraforte I, Chizzolini C, Frasca L. RB137 and RB138 antibodies recognize human cathelicidin LL37 by ELISA. Antib. Rep. 2020b; 3:e188. doi: 10.24450/journals/abrep.2020.e188
Navarro Quiroz E, Chavez-Estrada V, Macias-Ochoa K, et al. epigenetic mechanisms and posttranslational modifications in systemic lupus erythematosus. Int J Mol Sci. 2019; 20:5679. PMID: 31766160
Zanetti M. The role of cathelicidins in the innate host defenses of mammals. Curr Issues Mol Biol. 2005; 7:179-196. PMID: 16053249.
Copyright (c) 2020 The author(s)
This work is licensed under a Creative Commons Attribution 4.0 International License.